Question 1

What is the Meaning of Precision Oncology?

Accepted Answer

Precision Oncology represents a medical approach that customizes cancer treatment strategies based on the unique genetic and molecular characteristics of an individual's tumor. This method moves beyond traditional one-size-fits-all therapies by identifying specific biological markers within the cancer cells, guiding the selection of targeted interventions designed to be most effective for that patient. It prioritizes the specific tumor biology over the organ of origin.

Question 2

What is the Context of Precision Oncology?

Accepted Answer

This approach operates within the broader field of cancer therapy, shifting the focus from generalized cytotoxic treatments to highly specific molecular interventions. It is particularly relevant in cases where conventional therapies have limited efficacy or when a patient's tumor exhibits known actionable genetic alterations. Understanding the unique cellular signaling pathways driving a particular malignancy is central to its application.

Question 3

What is the Significance of Precision Oncology?

Accepted Answer

Precision Oncology holds substantial importance in clinical practice by offering the potential for improved treatment outcomes and reduced adverse effects compared to standard chemotherapy regimens. It allows clinicians to select therapies that are more likely to be effective for a given patient, potentially leading to longer disease control and enhanced quality of life. This tailored strategy optimizes therapeutic benefit while minimizing collateral damage to healthy tissues.

Question 4

What is the Mechanism of Precision Oncology?

Accepted Answer

The mechanism involves comprehensive genomic profiling of tumor tissue or circulating tumor DNA to detect specific mutations, gene amplifications, fusions, or protein expressions driving cancer growth. Once these molecular aberrations are identified, therapies are chosen that specifically inhibit the altered pathways or target the unique characteristics of the cancer cells. This precise targeting disrupts the tumor's ability to proliferate and survive.

Question 5

What is the Application of Precision Oncology?

Accepted Answer

In practice, Precision Oncology involves a multi-step process beginning with biopsy and subsequent molecular diagnostic testing, such as next-generation sequencing. The results inform clinical decisions, guiding the selection of FDA-approved targeted therapies, immunotherapies, or enrollment in relevant clinical trials. This strategy is applied across various cancer types, continually adapting as new biomarkers and therapeutic agents become available.

Question 6

What is the Metric of Precision Oncology?

Accepted Answer

The effectiveness of Precision Oncology interventions is typically monitored through various clinical and molecular metrics. Tumor response is frequently assessed using radiological imaging, such as CT or MRI scans, to measure changes in tumor size. Additionally, circulating tumor DNA (ctDNA) levels can serve as a non-invasive biomarker for disease burden and treatment response, complementing clinical assessments of patient well-being and symptom resolution.

Question 7

What is the Risk of Precision Oncology?

Accepted Answer

Potential risks associated with Precision Oncology include the development of acquired drug resistance, where tumor cells evolve to bypass the targeted therapy, necessitating a change in treatment. Off-target effects, though less common than with traditional chemotherapy, can still occur, leading to specific adverse reactions. Furthermore, the financial implications of advanced molecular testing and specialized drugs, along with the limited availability of targeted therapies for all identified alterations, represent practical challenges.

Precision Oncology

Meaning

Context

Significance

Mechanism

Application

Metric

Risk

How Do Androgen Receptor Mutations Affect Treatment Outcomes?